Log In
Print this Print this

FXIa antibody

  Manage Alerts
Collapse Summary General Information
Company Bayer AG
DescriptionFactor XIa targeting antibody
Molecular Target Factor XIa
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase I
Standard IndicationThrombosis
Indication DetailsTreat thrombosis
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today